36C25521Q0176 Sources Sought Notice.pdf

Contract Opportunity Sources Sought Notice

PRODUCT SERVICE CODE

SUBJECT

CONTRACTING OFFICE'S

ZIP-CODE

SOLICITATION NUMBER

RESPONSE DATE/TIME/ZONE

ARCHIVE DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS

SET-ASIDE

NAICS CODE

CONTRACTING OFFICE

ADDRESS

POINT OF CONTACT

(POC Information Automatically Filled from User Profile Unless Entered)

DESCRIPTION See Attachment

AGENCY'S URL

URL DESCRIPTION

AGENCY CONTACT'S EMAIL

ADDRESS

EMAIL DESCRIPTION

ADDRESS

POSTAL CODE

COUNTRY

ADDITIONAL INFORMATION

GENERAL INFORMATION

PLACE OF PERFORMANCE

* = Required Field Contract Opportunity Sources Sought Notice

Blood Bank Gel Reagents | Marion, IL VAMC and Poplar Bluff, MO VAMC

66048

36C25521Q0176

02-16-2021 4:00 pm CENTRAL TIME, CHICAGO, USA

N

325413

Department of Veterans Affairs Network Contracting Office (NCO) 15 3450 S 4th Street Trafficway

Leavenworth KS 66048

Jim Lewis james.lewis114fbb@va.gov

Marion, IL VAMC & Poplar Bluff, MO VAMC

USA

https://ww.va.gov

VA Website james.lewis114fbb@va.gov

Contract Specialist

This Sources Sought Notice is for planning purposes only and shall not be considered as an invitation for bid, request for quotation, request for proposal, or as an obligation on the part of the Government to acquire any products or services. Your response to this Sources Sought Notice will be treated as information only. No entitlement to payment of direct or indirect costs or charges by the Government will arise as a result of contractor submission of responses to this announcement or the Government use of such information. This request does not constitute a solicitation for proposals or the authority to enter into negotiations to award a contract. No funds have been authorized, appropriated, or received for this effort.

The information provided may be used by the Department of Veterans Affairs in developing its acquisition approach, statement of work/statement of objectives and performance specifications.

Interested parties are responsible for adequately marking proprietary or competition sensitive information contained in their response. The Government does not intend to award a contract on the basis of this Sources Sought Notice or to otherwise pay for the information submitted in response to this Sources Sought Notice.

The purpose of this sources sought announcement is for market research to make appropriate acquisition decisions and to gain knowledge of potential qualified Service Disabled Veteran Owned Small Businesses, Veteran Owned Small Businesses, 8(a), HubZone and other Small Businesses interested and capable of providing the services described below.

Documentation of technical expertise must be presented in sufficient detail for the Government to determine that your company possesses the necessary functional area expertise and experience to compete for this acquisition. Responses to this notice shall include the following:

(a) company name (b) address (c) point of contact (d) phone, fax, and email (e) DUNS number

(f) Cage Code (g) Tax ID Number (h) Type of small business, e.g. Services Disabled Veteran Owned small Business, Veteran-owned small business, 8(a), HUBZone, Women Owned Small Business, Small disadvantaged business, or Small Business HUBZone business and (i) must provide a capability statement that addresses the organizations qualifications and ability to perform as a contractor for the work described below.

The VA Heartland Network 15, Contracting Office located at 3450 South 4th Street, Leavenworth, KS, 66048-5055 is seeking a potential qualified contractor to provide Blood Bank Gel Reagents for Veterans Health Administration, Marion, IL VAMC and Poplar Bluff, MO

VAMC.

Classification System (NAICS) code for this acquisition is 325413 (In-Vitro Diagnostic Substance Manufacturing) with a size standard of 1,250 Employees.

Important information: The Government is not obligated to nor will it pay for or reimburse any costs associated with responding to this sources sought synopsis request. This notice shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued.

Currently a total set-aside for Service-Disabled Veteran Owned Small Business firms is anticipated based on the Veterans Administration requirement with Public Law 109-461, Section 8127 Veterans Benefit Act and VAAR 808.002 (Class Deviation), Priorities for use of Department of Veterans Affairs (VA).

However, if response by Service-Disabled Veteran Owned Small Business firms proves inadequate, an alternate set-aside or full and open solicitation may be published.

POTENTIAL SOURCES SHALL PROVIDE THE FOLLOWING INFORMATION IN THE

RESPONSE:

1) Company name, address, phone number, primary contact(s), e-mail address, NAICS code(s), business size (i.e. small/large), and DUNS Number.

2) Statement of Capability that demonstrates ability of providing the item in accordance with the attached Statement of Requirement (SOR) and past performance in providing this type of service. Include examples of prior completed Government contracts, references, and other related information.

This notice is to assist the NCO 15 in determining SOURCES ONLY. This announcement is not a request for proposals or quotations. The Government is not committed to award a contract pursuant to this announcement. The Government will not pay for any costs incurred in the preparation or submission of information in response to this announcement.

Notice to potential offerors: All offerors who provide goods or services to the United States Federal Government must be registered in the System for Award Management (SAM located on the web at www.sam.gov). Additionally, all Service Disabled Veteran Owned Businesses or Veteran Owned Businesses who respond must be registered with the Department of Veterans Affairs Center for Veterans Enterprise VetBiz Registry located at http://vip.vetbiz.gov.

Any response to this source sought from Interested parties must be received NLT February 16, 2021. Attention: Jim Lewis, Contracting Specialist. Email: james.lewis114fbb@va.gov http://vip.vetbiz.gov/ mailto:james.lewis114fbb@va.gov

STATEMENT OF REQUIREMENT

VA Heartland Network - VISN 15

Blood Bank Gel Reagents

DESCRIPTION/SPECIFICATIONS/STATEMENT OF WORK

SCOPE OF PROCUREMENT:

• It is the intent of the Department of Veterans Affairs to establish an agreement for Immunohematology Gel reagents for transfusion medicine testing.

• The desired reagents shall have the capability of performing as defined in this statement of requirements and shall be acquired for each of the clinical laboratories located within the VISN facilities listed in Attachment A.

• VISN 15 will provide an estimated volume by reagent as reflected in Attachment A for each individual medical center and outpatient clinic laboratory. The Government estimates the volumes per facility as listed in Attachment A, but does not guarantee volumes as listed; they are estimates ONLY.

• As requirements change, facilities within VISN 15 may be added or deleted by supplemental agreement of the Government and the Contractor. Additional reagents may be added to the BPA as new technology becomes available on the market.

• The agreement is for one base year and a one-year four optional period. VISN 15 intends to establish the base year of the agreement for the period of 04/30/2021 through 04/29/2022.

• The Contractor is required to provide a continuously stocked inventory of reagents, controls, and supplies required to ensure that patient care operations are not interrupted.

These items shall be of the highest quality, sensitivity, specificity and tested to assure precision and accuracy. Expiration date must be clearly marked on reagent, standards and control containers. Alert/Notification of any delays in shipment as well as any or all technical advisory/recalls/alerts, prior to or simultaneously with field alerts should be forwarded to the designated individuals determined as identified in Attachment A.

• Special handling for emergency orders of supplies: In the event that the supplies are found to be defective and unsuitable for use with the Contractor’s equipment, or the Contractor has failed to comply with the requirements for routine supply delivery, the Contractor is required to deliver the supplies within 24 hours of receipt of a verbal order for emergency delivery. If either circumstance has occurred, the Contractor shall deliver to the Government site in the most expeditious manner possible without additional cost to the Government, the necessary consumables in sufficient quantity as required to allow operation of the Contractor’s equipment for one week (under normal Government test load volume). If additional requests for emergency supply delivery are required by the Government, they shall be honored by the Contractor until the arrival at the laboratory of the monthly standing order/routine supplies delivery.

• The delivery terms for all items ordered under the BPA will be FOB Origin. Contractor will make shipping arrangements and prepay all shipping and handling costs. Contractor will promptly replace all Products lost or damaged in shipment. Contractor will be responsible for all disputes with the shipper and all insurance claims related to the shipment.

• Contractor will accept return of erroneously shipped Products, in accordance with the following: Contractor will credit Customer 100% of the Purchase Price for Products returned due to shipping errors, provided that Customer requests a Return Material Authorization (RMA) number from the Contractor in its notice to Contractor of a shipping error, and that Customer returns the Products within (30) days after its receipt of a RMA number. Returns will have RMA number written clearly on the outside of the shipping container. Contractor will not accept returns of Products ordered in error by Customer.

REAGENT MENU: Refer to Attachment A for a list of desired reagents and the estimated annual volumes per facility. This solicitation uses a Brand Name or Equal Description of the product required. This permits prospective contractors to offer products other than those specifically referenced by brand name.

GENERAL REQUIREMENTS:

• Technical Features:

o Products must be compatible with the ORTHO Workstation in place at Marion and Poplar Bluff VAMC’s.

o The following name brand or equivalent products should be available:

• 0.8% AFFIRMAGEN Reagent Red Cells (2 x 3 mL)

• 0.8% RESOLVE Panel A Reagents (11 x 3 mL)

• 0.8% RESOLVE Panel B Reagents (11 x 3 mL)

• 0.8% SELECTOGEN Reagent Red Blood Cells (2 x 10 mL)

• 0.8% SURGISCREEN Reagent Red Blood Cells (3 x 10 mL)

• A/B/D monoclonal and Reverse grouping Gel Card

• A/B/D monoclonal grouping Gel Card

• MTS Anti IgG Gel Card (5 x 20 mL)

• Confidence System Reagent Blood Cells (1 kit)

• ID-MTS Buffered Diluent 2 (5 x 100 mL)

• MTS Tips, Racked (12 x 96) o Products should be an FDA licensed product that allows for reading of the gel test card manually.

o Vendor should provide antigrams listing the antigen typing of cell in the screens and panels.

o Red cell suspensions must be 0.8% (unless otherwise specified) to allow for use with gel card testing.

o 0.8% SELECTOGEN reagents must be of group O cells tested by two independent labs using sources of antibody (except where precluded by the rarity of the antibody) to confirm the presence or absence of all blood group antigens specified on the Master List. Product should have a negative direct antiglobulin test using polyspecific Anti-human Globulin.

o RESOLVE reagents must be a 0.8% suspension of group O red blood cells.

Reagents must be tested by two independent labs using sources of antibody (except where precluded by the rarity of the antibody) to confirm the presence or absence of all blood group antigens specified on the Master List.

o ORTHO CONFIDENCE SYSTEM quality control kit must provide an antiserum containing a blend of polyclonal and monoclonal antibodies and a Group AB+ red blood cell suspension (2- 4%) to be used as a quality control product for red blood cell grouping reagents and antibody detection reagents.

o MTS Anti-IgG cards must be prepared from pools of sera obtained from rabbits that have been immunized with human IgG.

o ID-MTS Diluent 2 must be a hypotonic buffered saline solution formulated to give the appropriate pH and ionic strength levels compatible with gel used in the MTS ANTI-IgG Card.

o MTS Tips must be compatible with the ‘Biohit pipettes’ in use at Marion and Poplar Bluff VAMC.

• All products should be FDA licensed.

Attachment A Gel Reagents Feb 2021.x